Zions Bancorporation’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-986
| Closed | -$98K | – | 1021 |
|
|
2019
Q3 | $98K | Hold |
986
| – | – | 0.01% | 334 |
|
|
2019
Q2 | $91K | Sell |
986
-39
| -4% | -$3.7K | 0.01% | 313 |
|
|
2019
Q1 | $97K | Buy |
+1,025
| New | +$89.6K | 0.02% | 310 |
|
|
2018
Q4 | – | Sell |
-964
| Closed | -$86K | – | 846 |
|
|
2018
Q3 | $86K | Buy |
+964
| New | +$85.2K | 0.02% | 256 |
|
|
2018
Q2 | – | Sell |
-745
| Closed | -$66K | – | 760 |
|
|
2018
Q1 | $66K | Sell |
745
-162
| -18% | -$15.6K | 0.01% | 243 |
|
|
2017
Q4 | $95K | Sell |
907
-4,823
| -84% | -$544K | 0.02% | 240 |
|
|
2017
Q3 | $835K | Buy |
5,730
+5,583
| +3,798% | +$760K | 0.12% | 105 |
|
|
2017
Q2 | $19K | Sell |
147
-98
| -40% | -$12K | ﹤0.01% | 292 |
|
|
2017
Q1 | $30K | Sell |
245
-325
| -57% | -$38.9K | 0.01% | 240 |
|
|
2016
Q4 | $66K | Buy |
570
+41
| +8% | +$4.57K | 0.01% | 206 |
|
|
2016
Q3 | $54K | Buy |
529
+48
| +10% | +$5.2K | 0.01% | 223 |
|
|
2016
Q2 | $50K | Sell |
481
-48
| -9% | -$4.96K | 0.01% | 213 |
|
|
2016
Q1 | $57K | Sell |
529
-8
| -1% | -$824 | 0.01% | 223 |
|
|
2015
Q4 | $53K | Buy |
537
+66
| +14% | +$7.64K | 0.01% | 207 |
|
|
2015
Q3 | $55K | Buy |
+471
| New | +$58.5K | 0.01% | 207 |
|
|
2015
Q2 | – | Sell |
-532
| Closed | -$61K | – | 942 |
|
|
2015
Q1 | $61K | Buy |
+532
| New | +$63.6K | 0.01% | 203 |
|
Other funds holding CELG
Zions Bancorporation's CELG Position: Q4 2019 in Review
Zions Bancorporation sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 986 shares — an estimated $98K sold.
Zions Bancorporation first reported a position in CELG in Q1 2015 and held it in 16 quarters. The position peaked at $835K in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Zions Bancorporation reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Zions Bancorporation sold 986 Celgene Corp shares in Q4 2019, an estimated $98K.
- Zions Bancorporation first reported a position in Celgene Corp in Q1 2015 and held it in 16 quarters.
- Zions Bancorporation's Celgene Corp position peaked at $835K in Q3 2017.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Zions Bancorporation's 13F filing for Q4 2019, filed 14 Feb 2020.